TRANSLATIONAL ACCELERATOR
Translational Accelerator is a company that offers biomedical research and big data analytics services.
TRANSLATIONAL ACCELERATOR
Status:
Active
Similar Organizations
Sensus Retail
Sensus Retail is a company that uses communications technologies to data analytics and services.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-05-27 | Calimmune | Translational Accelerator investment in Series B - Calimmune | 15.85 M USD |
More informations about "Translational Accelerator"
The MND Translational Accelerator (MNDAcc)
The MND Translational Accelerator (MNDAcc) is a £6m investment by the Medical Research Council to quicken the development of treatments for MND, and the related condition of Frontotemporal dementia (FTD).See details»
Home - The Transition Accelerator
The Transition Accelerator is a pan-Canadian organization that works with others to identify and advance viable pathways to a prosperous, competitive, and net-zero Canada in 2050. Our Focus Areas: Our Approach About Us In our rapidly …See details»
Translational Therapeutics Accelerator - C-Path
The Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing …See details»
C-Path’s TRxA Announces $750,000 in Research Awards to …
TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced today its first two research grants supporting academic …See details»
NEW FUNDING OPPORTUNITY! C-Path's TRxA Announces its First …
May 15, 2024 About Translational Therapeutics Accelerator (TRxA) Critical Path Institute’s Translational Therapeutics Accelerator (TRxA) is a global drug accelerator focused on …See details»
Critical Path Institute - Translational Therapeutics …
The Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies for advancing …See details»
C-Path Launches Unique Translational Therapeutics …
Jun 9, 2022 The accelerator is a unique, global effort focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients.See details»
Our People - The Transition Accelerator
We’ve assembled a team of experts from across the country with the vision and skills to make Canada’s net-zero goals a reality. Meet the board and research directors who give us …See details»
Translational Therapeutics Accelerator (TRx) | Lab to Market ...
Oct 29, 2024 Pre-Proposal Applications for the 2024 - 2025 cycle are now closed. The Irving Institute Accelerate Program is a therapeutic development accelerator platform that plays a …See details»
C-Path Launches Unique Translational Therapeutics Accelerator …
The global accelerator will transform academic discoveries to drug development opportunities TUCSON, Ariz., June 9, 2022 — Critical Path Institute (C-Path) today announced it has been …See details»
Successfully navigating the valley of death: the importance of ...
Nov 21, 2023 An accelerator such as Critical Path Institute’s Translational Therapeutics Accelerator (TRxA) has a critical role in bridging the valley of death, where in addition to …See details»
C-Path’s TRxA Accelerates its First Drug Development Projects with ...
TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced today its first two research grants supporting academic …See details»
C-Path launches unique translational therapeu | EurekAlert!
Jun 9, 2022 The accelerator is a unique, global effort focused on supporting academic scientists in defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to …See details»
Accelerate - Irving Institute for Clinical and Translational Research
The Accelerate Resource is the Irving Institute’s home for translational therapeutics. Accelerate leverages Columbia’s proficiency in drug discovery and provide access to entrepreneurs and …See details»
C-Path Launches Unique Translational Therapeutics Accelerator …
TUCSON, Ariz., June 9, 2022 /PRNewswire/ -- Critical Path Institute (C-Path) today announced it has been awarded a grant from the Frederick Gardner Cottrell Foundation, a non-profit …See details»
Precision Medicine | Translational Accelerator - Harvard University
The Translational Accelerator’s mission is to utilize a comprehensive, industry-grade array of tools and resources to take fundamental biomedical discoveries through the technology/therapeutic …See details»
Putting translational science on to a global stage - Nature
Apr 1, 2016 Global collaboration in translational science promises to accelerate the discovery, development and dissemination of new medical interventions. Here, we introduce a new …See details»
Introduction to the National Cancer Imaging Translational …
Jul 27, 2021 The National Cancer Imaging Translational Accelerator (NCITA) is creating a UK national coordinated infrastructure for accelerated translation of imaging biomarkers for clinical …See details»
NCITA - National Cancer Imaging Translational Accelerator
Founded in 2019, NCITA is a national multi-site network of clinical imaging infrastructures, supported by a Cancer Research UK Accelerator Award of up to £10 million over 5 years.See details»
Translational Accelerator - Crunchbase
Translational Accelerator is a company that offers biomedical research and big data analytics services.See details»